Drug Pricing And The US Presidential Campaign: A Non-Issue?

The new US Medicare drug price negotiation authority got a brief mention during the 10 September presidential debate, not that anyone is likely to be talking about it afterwards.

Harris-Trump
Pharma likely is not disappointed drug pricing is not a major US presidential campaign issue. • Source: Shutterstock

More from Legislation

More from Pink Sheet